Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version.
about
Measuring patient activation in The Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13)Effect of patient-initiated versus fixed-interval telePRO-based outpatient follow-up: study protocol for a pragmatic randomised controlled study.Relationships between patient activation, disease-specific knowledge and health outcomes among people with diabetes; a survey study.Patient factors and glycaemic control--associations and explanatory power.Validation of the German version of the patient activation measure 13 (PAM13-D) in an international multicentre study of primary care patientsPsychometric evaluation of the German version of the Patient Activation Measure (PAM13)Psychometric properties of the hebrew translation of the patient activation measure (PAM-13)The effect of a patient portal with electronic messaging on patient activation among chronically ill patients: controlled before-and-after study.Measuring patient engagement: development and psychometric properties of the Patient Health Engagement (PHE) Scale.Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)Patient activation in Europe: an international comparison of psychometric properties and patients' scores on the short form Patient Activation Measure (PAM-13).Consumer Use of "Dr Google": A Survey on Health Information-Seeking Behaviors and Navigational NeedsEngaging hospitalized patients in clinical care: Study protocol for a pragmatic randomized controlled trial.Expectations, effect and experiences of an easily accessible self-management intervention for people with chronic pain: study protocol for a randomised controlled trial with embedded qualitative study.Adaptation and Validation of a Chinese Version of Patient Health Engagement Scale for Patients with Chronic Disease.Increasing Patient Activation Could Improve Outcomes for Patients with Inflammatory Bowel Disease.Adaptation to European Spanish and psychometric properties of the Patient Activation Measure 13 in patients with chronic diseases.Validation of the Patient Activation Measure (PAM-13) among adults with cardiac conditions in Singapore.The Lay Health Educator Program: Evaluating the Impact of this Community Health Initiative on the Medical Education of Resident Physicians.The Patient Activation Measure: a validation study in a neurological population.Patient activation and health literacy as predictors of health information use in a general sample of Dutch health care consumers.Evaluation of the psychometric characteristics of the Spanish version of the Anorectic Behaviour Observation Scale.Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.Key attributes of patient centered medical homes associated with patient activation of diabetes patients.Effect of a participant-driven health education programme in primary care for people with hyperglycaemia detected by screening: 3-year results from the Ready to Act randomized controlled trial (nested within the ADDITION-Denmark study).Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases.Effect on motivation, perceived competence, and activation after participation in the ''Ready to Act'' programme for people with screen-detected dysglycaemia: a 1-year randomised controlled trial, Addition-DK.Cancer survivors' activation to self-management and its relationship with participation in paid work and work-related problems.Adaptation and validation of the German Patient Activation Measure for adolescents with chronic conditions in transitional care: PAM® 13 for Adolescents.Recall of HbA1c and self-management behaviours, patient activation, perception of care and diabetes distress in Type 2 diabetes.Patient and treatment characteristics associated with patient activation in patients undergoing hemodialysis: a cross-sectional study.
P2860
Q21257282-45BAA306-0BE8-435D-8478-0E651B3012F6Q30490784-ADAE0B00-0DA2-4AF0-B103-37102B91B16AQ34246489-41A25980-4284-4ABE-BA24-47B82B35ECDBQ34271471-73433E06-6A15-4EEB-BF27-6E5B3F91E1ABQ34375702-661C9798-1F76-430E-964A-D587DA38E2AAQ34493773-EE12F68D-BD98-4304-B446-18CA652DC03FQ34549959-E4524064-6CE8-402F-B72D-437A5384DBC6Q34658461-C940A7BB-37DE-4ADD-A573-F2DA5FA97508Q35222870-28D2AB57-EA41-4527-BD16-F4983E8F66DCQ35877368-D4F879BF-E273-452D-969F-5E270A97D064Q36160901-EBE278EA-2648-43AC-8EB1-7449F58C08C4Q36457010-B55706D3-483E-45B6-9095-DB7DBB1EB0B2Q36757728-B018A136-E5FC-4DA3-807D-46FD599DFFC0Q37106515-DCCA0C51-00BB-4798-901D-F9210BBB774BQ37625376-D05EF60E-5ACB-4D9B-903A-C2748FBF4823Q38595814-EA58AB64-85D0-4DD9-9062-52C72658EEC1Q38734706-582E045D-18AC-4F09-A63A-E0BCEBA440A3Q39373756-7BCD3BF3-D194-4C31-BC26-B50A10AC13DDQ41244248-D28032B6-D276-42B0-8047-2ECAFDA2C537Q41627430-98763BEB-B789-4D9B-85C3-C4696AA4FE95Q45566489-37502DE0-F5D5-4629-9693-9F175A80BA49Q46686543-D5232D76-622A-4E14-ABE9-12A586FF83E5Q46885930-0E75B127-801F-4F12-8ED6-18FF99D0FC17Q47565017-8AD0EA02-4FBD-47E2-9EC1-5FD563D65C08Q47788263-28F35A71-BCA8-452B-B907-9CFC45AB583DQ48036502-CD656E6A-FD73-437E-AA90-AB5966DB05AFQ48146809-05A44A83-D750-4E32-9C84-B52C75DCDDA0Q48224444-A78B0C0C-29E0-4BCA-8C7F-211EA1DCB078Q48368941-D307A0B5-7FD3-4597-BAE2-2315A543A4C7Q50727170-10ADBE35-AC74-4596-AFEB-70F6133E596EQ54980721-61A02318-65F2-43E2-BD2D-23B54DEEE5EF
P2860
Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@ast
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@en
type
label
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@ast
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@en
prefLabel
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@ast
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@en
P2860
P356
P1433
P1476
Translation, adaptation and va ...... e (PAM13) in a Danish version.
@en
P2093
Ineta Sokolowski
P2860
P2888
P356
10.1186/1471-2458-9-209
P407
P577
2009-06-29T00:00:00Z
P5875
P6179
1039109588